|
We hereby
announce that "Research for developing a new immunosensor to
detect tumor markers in urine" a subject which
TRANS GENIC Inc. (hereinafter referred to as "we") had applied
for a program of "Hyogo COE Program Promotion Project" (hereinafter
referred to as "the Project"), was adopted by Hyogo Prefecture
in Japan.
The Project was a part of "Hyogo 21st Century Industry Promotion
Strategy" promoted by Hyogo Prefecture to boost its economy
and employment. In this Project, several subjects, among entries
from industry-academic-government research teams which conduct
preliminary researches, were chosen by the Hyogo prefectural
government to financially support them.
We have focused on an ultrasensitive electrochemical immunosensor,
an achievement made by Fumio Mizutani, professor of Graduate
School of Material Science, School of Science, University of
Hyogo, to develop a simple, speedy, affordable and small measuring
device by combining the immunosensor with our simple method for
cancer diagnosis using urine samples. Then we applied the attempt
as a subject for the Project and it was adopted by the prefectural
government.
According to statistics released by the Ministry of Health, Labour
and Welfare, more than 320 thousand people died of cancers in 2006,
remaining the leading killer in Japan. Establishing methods which
allow early diagnosis of cancers are in high demand in order to detect
and treat them in the earliest possible stages.
Responding to such social demands, we especially targeted tumor markers
secreted in urine in the early stages of cancers and successfully
developed monoclonal antibodies which show high-affinity and high-specificity
against them. We are now working toward practical use of the antibodies
for cancer diagnosis.
In our research project selected by Hyogo Prefecture, we aim to establish
a new method to detect tumor markers in urine using a newly developed
immunosensor, by combining a simple and speedy detection method of
immunochromatography with an electrochemical quantitative analysis
method.
We intend to carry out research and development under a close relationship
with University of Hyogo based on various contracts with them.
The
potential influences of this matter on our business performance
for the fiscal term ending March 2009 are as yet immaterial.
Reference:
|
